Target intelligence / Profile preview

Acetylcholine-sensitive muscarinic potassium channel (IK(ACh))

Target
IK(ACh)
Molecular classification
Ion channel, G protein-coupled inwardly rectifying potassium channel (GIRK), Receptor-coupled channel
01

Overview

The acetylcholine-sensitive muscarinic potassium channel, often referred to as IK(ACh) or the muscarinic K+ channel, is a subtype of inwardly rectifying potassium channel present in cardiac tissues. Upon stimulation by acetylcholine via muscarinic M2 receptors, the channel opens through a G protein (especially Gi/o) βγ subunit-mediated pathway, markedly increasing potassium conductance across cardiac cell membranes. This process hyperpolarizes cardiac cells, particularly in the atrium and sinoatrial node, thereby slowing the heart rate and contributing to the parasympathetic regulation of cardiac rhythm. The channel can also be activated by adenosine and is susceptible to modulation by muscarinic agonists and antagonists. Dysfunction or inappropriate regulation of IK(ACh) can contribute to cardiac arrhythmias and diseases involving heart rate control[1][2][3].

Other names
Muscarinic K+ channelKACh channelIK(ACh)Acetylcholine-activated potassium channel
02

Mechanism of action

Activation: Acetylcholine binds to muscarinic M2 receptors, leading to βγ subunit dissociation from Gi/o proteins, directly gating and opening the GIRK (IK(ACh)) channel, resulting in increased K+ conductance and cell hyperpolarization[1][2]. Blockade: Muscarinic antagonists inhibit the M2 receptor, preventing channel activation and depolarizing cardiac pacemaker cells[1][2].

03

Biological functions

Regulation of cardiac excitabilityModulation of heart rateSignal transductionRegulation of cardiac contractility
04

Disease associations

Cardiovascular diseaseArrhythmiaHeart rate disordersNeurogenic syncope
05

Safety considerations

Excessive activation can cause bradycardia and potentially fatal arrhythmiasblockade can cause tachycardia and reduced vagal cardiac protection[1][2][3]
06

Interacting drugs

Acetylcholine

4 more in the full profile.

Beyond the preview

Go deeper on Acetylcholine-sensitive muscarinic potassium channel (IK(ACh)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetylcholine-sensitive muscarinic potassium channel (IK(ACh)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call